← Open Payments lookup

PETER TRIPORO: Open Payments

NPI 1184050544 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,586 in 165 payments from 20 companies in 2025. Trend: 2023 $2,801 · 2024 $2,923 · 2025 $3,586

Food & beverage: $3,586
CompanyPaymentsAmount
ViiV Healthcare Company71$1,670
Gilead Sciences, Inc.25$467
Merck Sharp & Dohme LLC14$349
EMD Serono, Inc.11$188
ABBVIE INC.9$158
Otsuka America Pharmaceutical, Inc.8$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$106
Napo Pharmaceuticals Inc3$87
PFIZER INC.4$86
Theratechnologies Inc.3$82

Products named: CABENUVA, DOVATO, APRETUDE, PIFELTRO, REXULTI, RUKOBIA, VRAYLAR, CAPLYTA.

Industry payments across TX — which companies pay providers there.